Post job

Explore jobs

Find specific jobs

Explore careers

Explore professions

Best companies

Explore companies

AgeneBio Leadership

Zippia score 3.6
OverviewRevenue

Reviews

CEO & Executives

AgeneBio executives

Here are further demographic highlights of the leadership team:
  • The AgeneBio executive team is 43% female and 57% male.
  • 71% of the management team is White.
  • 11% of AgeneBio management is Hispanic or Latino.
  • 11% of the management team is Black or African American.
Work at AgeneBio?
Share your experience

Rate AgeneBio's leaders' effectiveness in guiding the company.

Zippia waving zebra
Name & TitleBio
Michela Gallagher Ph.D., Founded Agenebio In 2008 and Serves As Ceo. Dr. Gallagher Is the Krieger-Eisenhower Professor of Psychological and Brain Science and Heads the Neurogenetics and Behavior Center At Johns Hopkins University. She Is A Fellow of the American Psychological Association, the American Psychological Society and the American Association For the Advancement of Science. She Has Spent 20 Years Researching Memory and Learning As Well As the Neurobiology of Aging, Having Published More Than 250 Peer-Reviewed Papers, and Brings This Expertise To the Company As It Seeks To Advance Discoveries To Address Amnestic Mild Cognitive Impairment and Alzheimer’S Disease. She Has Served the On Boards of Scientific Counselors At the National Institute of Mental Health and the National Institute On Aging, the Scientific Advisory Board of the Stanley Center At the Broad Institute and the Advisory Board of Dzne, the German Center For Neurodegenerative Diseases.

Board Member

Michela Gallagher Ph.D., Founded Agenebio In 2008 and Serves As Ceo. Dr. Gallagher Is the Krieger-Eisenhower Professor of Psychological and Brain Science and Heads the Neurogenetics and Behavior Center At Johns Hopkins University. She Is A Fellow of the American Psychological Association, the American Psychological Society and the American Association For the Advancement of Science. She Has Spent 20 Years Researching Memory and Learning As Well As the Neurobiology of Aging, Having Published More Than 250 Peer-Reviewed Papers, and Brings This Expertise To the Company As It Seeks To Advance Discoveries To Address Amnestic Mild Cognitive Impairment and Alzheimer’S Disease. She Has Served the On Boards of Scientific Counselors At the National Institute of Mental Health and the National Institute On Aging, the Scientific Advisory Board of the Stanley Center At the Broad Institute and the Advisory Board of Dzne, the German Center For Neurodegenerative Diseases.'s LinkedIn

Floyd Bloom

Board Member

Kenneth G. Payie

Board Member

Richard B. Carter

Head of Business Development and Licensing

Richard Mohs

Vice President of Clinical Development

Richard Mohs's LinkedIn

Russell Barton

Board Member

Sarita Foster

Board Member

Sharon Rosenzweig-Lipson

Vice President

Sharon Rosenzweig-Lipson's LinkedIn

Charles Clarvit

Board Member

Darryle Schoepp

Board Member

Do you work at AgeneBio?

Does the leadership team provide a clear direction for AgeneBio?

AgeneBio jobs

AgeneBio founders

Name & TitleBio
Michela Gallagher Ph.D., Founded Agenebio In 2008 and Serves As Ceo. Dr. Gallagher Is the Krieger-Eisenhower Professor of Psychological and Brain Science and Heads the Neurogenetics and Behavior Center At Johns Hopkins University. She Is A Fellow of the American Psychological Association, the American Psychological Society and the American Association For the Advancement of Science. She Has Spent 20 Years Researching Memory and Learning As Well As the Neurobiology of Aging, Having Published More Than 250 Peer-Reviewed Papers, and Brings This Expertise To the Company As It Seeks To Advance Discoveries To Address Amnestic Mild Cognitive Impairment and Alzheimer’S Disease. She Has Served the On Boards of Scientific Counselors At the National Institute of Mental Health and the National Institute On Aging, the Scientific Advisory Board of the Stanley Center At the Broad Institute and the Advisory Board of Dzne, the German Center For Neurodegenerative Diseases.

Board Member

Michela Gallagher Ph.D., Founded Agenebio In 2008 and Serves As Ceo. Dr. Gallagher Is the Krieger-Eisenhower Professor of Psychological and Brain Science and Heads the Neurogenetics and Behavior Center At Johns Hopkins University. She Is A Fellow of the American Psychological Association, the American Psychological Society and the American Association For the Advancement of Science. She Has Spent 20 Years Researching Memory and Learning As Well As the Neurobiology of Aging, Having Published More Than 250 Peer-Reviewed Papers, and Brings This Expertise To the Company As It Seeks To Advance Discoveries To Address Amnestic Mild Cognitive Impairment and Alzheimer’S Disease. She Has Served the On Boards of Scientific Counselors At the National Institute of Mental Health and the National Institute On Aging, the Scientific Advisory Board of the Stanley Center At the Broad Institute and the Advisory Board of Dzne, the German Center For Neurodegenerative Diseases.'s LinkedIn

AgeneBio board members

Name & TitleBio
Michela Gallagher Ph.D., Founded Agenebio In 2008 and Serves As Ceo. Dr. Gallagher Is the Krieger-Eisenhower Professor of Psychological and Brain Science and Heads the Neurogenetics and Behavior Center At Johns Hopkins University. She Is A Fellow of the American Psychological Association, the American Psychological Society and the American Association For the Advancement of Science. She Has Spent 20 Years Researching Memory and Learning As Well As the Neurobiology of Aging, Having Published More Than 250 Peer-Reviewed Papers, and Brings This Expertise To the Company As It Seeks To Advance Discoveries To Address Amnestic Mild Cognitive Impairment and Alzheimer’S Disease. She Has Served the On Boards of Scientific Counselors At the National Institute of Mental Health and the National Institute On Aging, the Scientific Advisory Board of the Stanley Center At the Broad Institute and the Advisory Board of Dzne, the German Center For Neurodegenerative Diseases.

Board Member

Michela Gallagher Ph.D., Founded Agenebio In 2008 and Serves As Ceo. Dr. Gallagher Is the Krieger-Eisenhower Professor of Psychological and Brain Science and Heads the Neurogenetics and Behavior Center At Johns Hopkins University. She Is A Fellow of the American Psychological Association, the American Psychological Society and the American Association For the Advancement of Science. She Has Spent 20 Years Researching Memory and Learning As Well As the Neurobiology of Aging, Having Published More Than 250 Peer-Reviewed Papers, and Brings This Expertise To the Company As It Seeks To Advance Discoveries To Address Amnestic Mild Cognitive Impairment and Alzheimer’S Disease. She Has Served the On Boards of Scientific Counselors At the National Institute of Mental Health and the National Institute On Aging, the Scientific Advisory Board of the Stanley Center At the Broad Institute and the Advisory Board of Dzne, the German Center For Neurodegenerative Diseases.'s LinkedIn

Floyd Bloom

Board Member

Kenneth G. Payie

Board Member

Russell Barton

Board Member

Sarita Foster

Board Member

Charles Clarvit

Board Member

Darryle Schoepp

Board Member

Dr. Gallagher Rose Through the Faculty Ranks At University of North Carolina At Chapel Hill Prior To Joining Johns Hopkins In 1997 Where She Was the Kenan Professor of Psychology. She Earned Her Ph.D. In Physiological Psychology From University of Vermont.

Board Member

Dr. Schoepp Received His Bachelor’S Degree In Pharmacy From North Dakota State University and His Doctoral Degree In Pharmacology and Toxicology From West Virginia University.

Board Member

Rod Dowler

Board Member

AgeneBio executives FAQs

Most in demand jobs

Updated November 18, 2022

Zippia gives an in-depth look into the details of AgeneBio, including salaries, political affiliations, employee data, and more, in order to inform job seekers about AgeneBio. The employee data is based on information from people who have self-reported their past or current employments at AgeneBio. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by AgeneBio. The data presented on this page does not represent the view of AgeneBio and its employees or that of Zippia.

AgeneBio may also be known as or be related to AgeneBio, AgeneBio Inc, AgeneBio Inc., AgeneBio, Inc. and Agenebio Inc.